BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9389571)

  • 21. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases.
    Medema RH; Klompmaker R; Smits VA; Rijksen G
    Oncogene; 1998 Jan; 16(4):431-41. PubMed ID: 9484832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas.
    Taguchi T; Kato Y; Baba Y; Nishimura G; Tanigaki Y; Horiuchi C; Mochimatsu I; Tsukuda M
    Oncol Rep; 2004 Feb; 11(2):421-6. PubMed ID: 14719078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased growth inhibitory responses of squamous carcinoma cells to interferon-gamma involve failure to recruit cki proteins into cdk2 complexes.
    Harvat BL; Jetten AM
    J Invest Dermatol; 2001 Nov; 117(5):1274-81. PubMed ID: 11710944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin-dependent kinase inhibitor (roscovitine) suppresses growth and induces apoptosis by regulating Bcl-x in head and neck squamous cell carcinoma cells.
    Mihara M; Shintani S; Kiyota A; Matsumura T; Wong DT
    Int J Oncol; 2002 Jul; 21(1):95-101. PubMed ID: 12063555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
    Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS
    Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1.
    Peterson SR; Gadbois DM; Bradbury EM; Kraemer PM
    Cancer Res; 1995 Oct; 55(20):4651-7. PubMed ID: 7553644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells.
    Jakus J; Yeudall WA
    Oncogene; 1996 Jun; 12(11):2369-76. PubMed ID: 8649777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
    Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
    Al-Aynati MM; Radulovich N; Ho J; Tsao MS
    Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.
    Malliri A; Yeudall WA; Nikolic M; Crouch DH; Parkinson EK; Ozanne B
    Cell Growth Differ; 1996 Oct; 7(10):1291-304. PubMed ID: 8891333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
    Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
    Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.
    Takano Y; Kato Y; van Diest PJ; Masuda M; Mitomi H; Okayasu I
    Am J Pathol; 2000 Feb; 156(2):585-94. PubMed ID: 10666388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
    Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
    Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes.
    Mouriaux F; Casagrande F; Pillaire MJ; Manenti S; Malecaze F; Darbon JM
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):876-84. PubMed ID: 9579467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.